Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 74 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
731 14.4 months Advanced NSCLC 5 Biologic therapy
Dana-Farber Cancer Institute United States 11/2013
Treatment Details: Patients: This phase 3 study involved advanced non-small-cell lung cancer patients who were separated into two different treatment groups. Group A consisted of 373 patients with a median a
 
732 14.4 months Castration-Resistant Prostate Cancer 5 Radiation
Mount Vernon Cancer Centre United Kingdom 11/2014
Treatment Details: Patients: This phase 3 study involved castration-resistant prostate cancer patients with bone metastases who were divided into two groups based on prior treatment. Group A had 352 patients
 
733 14.4 months Advanced NSCLC 4 Chemotherapy
Shizuoka Cancer Center Hospital Japan 8/2006
Treatment Details: Patients: This phase II study involved 128 patients with stage IIIB or IV non-small cell lung cancer. These patients were randomly divided into two groups of 64, GC and GV. The median age
 
734 14.3 months Advanced NSCLC 4 Chemotherapy
Oncology Institute of Bari Italy 12/2001
Treatment Details: Patients: This Phase I/II study involved 41 (Phase II) patients with advanced (stage IIIB or IV) non-small cell lung cancer. Treatment: The treatment consisted of three drugs, paclitaxel
 
735 14.3 months Advanced urothelial carcinoma 5 Biologic therapy
Chemotherapy
University of Michigan United States 5/2014
Treatment Details: Patients: This phase 2 study involved advanced urothelial carcinoma patients who were divided into two separate treatment groups. Group A consisted of 28 patients with a median age of 65.8
 
736 14.3 months T-cell lymphoma 4 Chemotherapy
Hormone
Fukuoka University Japan 5/2010
Treatment Details: Patients: This phase II study involved 53 patients with T-cell lymphoma. The median patient age was 66 years and 26 were male. Treatment: Patients were treated with the chemotherapy ag
 
737 14.2 months Advanced bladder cancer 5 Chemotherapy
Institut Gustave Roussy France 5/2012
Treatment Details: Patients: This study involved 45 advanced bladder cancer patients who had been previously treated with a platinum–gemcitabine regimen. The median patient age was 58 years and 80% were male
 
738 14.2 months NSCLC 5 Chemotherapy
NHO Shikoku Cancer Center Japan 1/2012
Treatment Details: Patients: This phase II study involved 31 previously treated non-small cell lung cancer patients with a median age of 66 years; 21 were males. Treatment: Patients were treated with the
 
739 14.2 months Advanced NSCLC 4 Chemotherapy
Kinki University School of Medicine Japan 2/2012
Treatment Details: Patients: This study involved 55 elderly non-small-cell lung cancer patients who had not received prior chemotherapy. The median patient age was 76 years (range of 71 to 86) and 37 were ma
 
740 14.2 months Squamous NSCLC 5 Biologic therapy
Chemotherapy
Dnepropetrovsk Medical Academy Ukraine 5/2015
Treatment Details: Patients: This phase 2 study involved 38 advanced/metastatic squamous non-small-cell lung cancer patients who had not received prior chemotherapy. The median patient age was 59.5 years and
 
Page 74 of 187  | Previous Page  | Next Page